30.3% Below Target

The consensus Wall Street price target for DHR is $230.89, representing 30.3% upside from the current price of $177.17. With 43 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

DHR has a consensus rating of "Buy" based on 43 Wall Street analysts. The rating breakdown is predominantly bullish, with 30 Buy/Strong Buy ratings. The consensus 12-month price target of $230.89 implies 30.3% upside from current levels.

DHR trades at a forward P/E of 20.9932x, representing a moderate valuation. With analysts targeting $230.89 (30.3% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $265 for DHR, while the most conservative target is $200. The consensus of $230.89 represents the median expectation. Our quantitative valuation model projects a bull case target of $362 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

DHR is heavily covered by Wall Street, with 43 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 29 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month DHR stock forecast based on 43 Wall Street analysts shows a consensus price target of $230.89, with estimates ranging from $200 (bear case) to $265 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $275, with bear/bull scenarios of $173/$362.

Our quantitative valuation model calculates DHR's fair value at $275 (base case), with a bear case of $173 and bull case of $362. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.

DHR trades at a forward P/E ratio of 21.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 35.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on DHR, with a "Buy" consensus rating and $230.89 price target (30.3% upside). 30 of 43 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

DHR analyst price targets range from $200 to $265, a 28% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $230.89 consensus represents the middle ground. Our model's $173-$362 range provides an independent fundamental perspective.